首页> 美国卫生研究院文献>Contemporary Clinical Trials Communications >Preliminary analysis of the effect of Stevia (Stevia rebaudiana) in patients with chronic kidney disease (stage I to stage III)
【2h】

Preliminary analysis of the effect of Stevia (Stevia rebaudiana) in patients with chronic kidney disease (stage I to stage III)

机译:甜叶菊(甜叶菊)对慢性肾脏疾病(I期至III期)患者的疗效初步分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundStevia, Stevia rebaudiana (Bertoni), has become an important economic plant for its commercial use as a sweetener. Stevia plays a significant role in the healthcare practice of different cultures and in population. Previous animal and clinical studies demonstrated the efficacy of Stevia against chronic diseases like diabetes and hypertension. This study aimed to investigate the beneficial effect of Stevia in chronic kidney disease (CKD) patients after three (3) months of treatment along with the conventional antihypertensive and anti diabetic medications.
机译:背景甜叶菊,甜叶菊甜叶菊(Bertoni),已作为其商业上用作甜味剂的重要经济植物。甜叶菊在不同文化和人群的医疗保健实践中起着重要作用。先前的动物和临床研究表明,甜菊糖对糖尿病和高血压等慢性疾病有效。这项研究旨在研究甜菊糖在三(3)个月的治疗以及传统的降压和抗糖尿病药物治疗后对慢性肾脏病(CKD)患者的有益作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号